Bilateral Eyelid Myokymia: Benign Condition Related to Stress and Medications
This patient's bilateral eyelid twitching (myokymia) is almost certainly a benign, self-limited condition unrelated to ALS or brain tumor, and is most likely triggered by a combination of anxiety, weight gain, and her current medications—particularly anastrozole, propranolol, and escitalopram.
Clinical Reassurance
Eyelid myokymia limited to the eyelids is a benign condition that does not progress to serious neurologic disease. Chronic isolated eyelid myokymia tends not to be associated with other neurologic disorders and does not represent the first manifestation of conditions like ALS or brain tumors 1.
The patient's normal CBC, CMP, and recent CT scan without metastases effectively rule out metabolic derangements, brain tumors, and metastatic disease as causes of her symptoms.
The bilateral nature of her myokymia, worsening with eye closure, and intermittent quality are classic features of benign eyelid myokymia rather than pathologic facial myokymia (which typically involves broader facial muscles and suggests brainstem pathology) 2.
Most Likely Contributing Factors
Medication-Related Triggers
Anastrozole can cause neuromuscular side effects. While not commonly listed as causing myokymia specifically, aromatase inhibitors like anastrozole have been associated with various ocular and neuromuscular manifestations 3. The drug's mechanism of lowering estrogen levels may contribute to neuromuscular irritability.
Propranolol (beta-blocker) can paradoxically cause or worsen muscle twitching in some patients through effects on neuromuscular transmission.
Escitalopram (Lexapro) and other SSRIs have been associated with various movement-related side effects and may contribute to myokymia through serotonergic mechanisms.
Psychosocial and Metabolic Factors
Anxiety and fear (evident in her "scared to death" presentation) are major triggers for eyelid myokymia 1. Her cancer diagnosis and ongoing treatment create significant psychological stress.
Recent 15-pound weight gain and obesity (BMI ~37) may contribute through multiple mechanisms including sleep disturbance, metabolic stress, and potential vitamin deficiencies.
The occasional difficulty taking a deep breath is likely anxiety-related (consistent with her fear and stress) rather than a neuromuscular disorder, especially given normal labs and imaging.
Management Algorithm
Immediate Reassurance and Education
Provide firm reassurance that this is NOT ALS or a brain tumor. ALS does not present with isolated bilateral eyelid twitching, and her recent negative CT scan rules out structural brain lesions 1, 2.
Explain that eyelid myokymia is extremely common, self-limited (typically resolving within weeks to months), and does not indicate serious disease 1.
Lifestyle Modifications (First-Line)
Reduce caffeine intake completely if she consumes coffee, tea, or energy drinks.
Optimize sleep hygiene: aim for 7-8 hours of quality sleep nightly, as sleep deprivation is a major trigger 1.
Stress reduction techniques: cognitive behavioral therapy, mindfulness, or formal anxiety treatment given her significant cancer-related anxiety.
Address the breathing difficulty: teach diaphragmatic breathing exercises for anxiety-related dyspnea.
Medication Review
Consider checking vitamin B12 levels, as some medications (though metformin is the classic culprit) can affect B12 absorption, and deficiency may contribute to neuromuscular symptoms 4.
Do NOT discontinue anastrozole without oncology consultation, as it is critical for her stage 1 invasive ductal carcinoma treatment 5. The survival benefit far outweighs the nuisance of myokymia.
Evaluate whether propranolol is essential or if the dose can be reduced, as beta-blockers may contribute to muscle twitching.
Continue escitalopram as anxiety management is crucial, and the benefit likely outweighs any potential contribution to myokymia.
Observation Period
Expect spontaneous resolution within 3-6 months in most cases 1. In a study of chronic eyelid myokymia, 27% resolved spontaneously without intervention.
Follow-up in 2-3 months to reassess symptoms. If myokymia persists beyond 6 months and significantly impacts quality of life, consider referral to ophthalmology or neurology.
If Symptoms Persist or Worsen
Botulinum toxin injection is highly effective for chronic, distressing eyelid myokymia that does not resolve spontaneously 1. In one series, 73% of patients with chronic myokymia treated with botulinum toxin reported significant improvement.
Neuroimaging is NOT indicated unless the myokymia progresses to involve other facial muscles (suggesting facial myokymia rather than isolated eyelid myokymia) or new neurologic symptoms develop 1, 2.
Red Flags That Would Change Management
Progression to involve other facial muscles (cheek, mouth beyond just lip) would warrant MRI to evaluate for brainstem pathology or demyelinating disease 2.
Development of true weakness, atrophy, fasciculations elsewhere, or bulbar symptoms would necessitate neurology referral and EMG, though this is extremely unlikely given the current presentation.
Continuous (rather than intermittent) twitching or rhythmic movements would suggest a different diagnosis.
Weight Management Consideration
- Address the 15-pound weight gain through dietary counseling and exercise, as this may improve both the myokymia and the breathing difficulty. Weight loss may also reduce anxiety and improve sleep quality, addressing multiple contributing factors simultaneously.